Description: Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Home Page: www.scorpiusbiologics.com
627 Davis Drive
Morrisville,
NC
27560
United States
Phone:
919 240 7133
Officers
| Name | Title |
|---|---|
| Mr. Jeffrey Alan Wolf J.D. | Founder, Chairman, President & CEO |
| Mr. William L. Ostrander | CFO, Controller & Secretary |
| Ms. Abby Sorensen | Senior Marketing & Sales Development Manager |
| Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D. | Chief Medical Advisor and Member of Scientific & Clinical Advisory Board |
| Colonel George E. Peoples Jr., F.A.C.S., M.D. | Chief Medical Advisor |
| Ms. Ania Szymanska | Site Head of Quality |
| Mr. Joe Payne | President & COO of Scorpius BioManufacturing |
| Ms. Nicole Temple | Head of Program Management |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 82 |